Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2013-04-22

Clinical Trial Update: A Study to Evaluate the Effects of Calcium Carbonate and Ferrous Fumarate on Pharmacokinetics of Dolutegravir in Healthy Adult Subjects [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the effect of calcium carbonate and ferrous fumarate on the pharmacokinetics of dolutegravir in healthy adult subjects.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Calcium carbonate (Calcium carbonate)
  • Ferrous Fumarate (ferrous fumarate)
  • Tivicay (dolutegravir)

Snippet

Sponsor: ViiV Healthcare | Conditions: Infection, Human Immunodeficiency Virus | Phase 1 | Status: COMPLETED